It is a scalable play on India’s evolving healthcare demand
Short-cycle orders stay strong, QCO weighs on margins for now
The company is expanding shipbuilding capacity and exploring greenfield opportunities
Near-term earnings growth likely to be sustained, helped by strategic deals
Incremental capacity expansion at the Umbergaon facility will aid growth in the scholastic segment as manufacturing constraints ease
The company is collaborating with large pharma clients on ADC chemistry. ADCs are a class of complex molecules used in targeted cancer therapy
Strong parent backing, clean balance sheet, and huge export potential
Robust PowerGen growth, margin resilience offset temporary export softness
Risk-reward not favourable, though profitability is solid and the guidance is upbeat
Growth likely to accelerate from FY27, as the company retains order inflow guidance for FY26
The upcoming greenfield projects will help Medanta to establish a presence in western and eastern India
Growth revival in the core portfolio, rising contribution of high-margin brands, and stable cost environment expected to aid profitable growth
The company’s expansion story is encouraging, but profitability and valuations remain a concern
The projected industry oversupply poses a serious risk to the solar sector's profitability
The company’s upstream strength matches downstream acceleration
Trent is enhancing store density in the existing markets as well as entering newer markets which offer huge growth opportunities
With a cash balance of more than Rs 3,200 crore, the company appears well-positioned for further investments to tap upcoming opportunities
The company posts a steady performance in Q2FY26
Apollo is well positioned to benefit from the rising healthcare demand in India
The contract manufacturer’s outlook is bright as its business diversification strategy is working out
Quarterly performance was driven by strong exports and a premium mix
The company has navigated the tough environment well and remains on track to accelerate growth
High valuation prices in the positives that may take time to fructify
The company is doing well and gold demand is also robust. However, the stock has priced in most of the positives
Project pipeline and capex guidance boost earnings visibility